Facebook
Twitterhttps://creativecommons.org/publicdomain/zero/1.0/https://creativecommons.org/publicdomain/zero/1.0/
The datasets featured below were created by reconciling thyroid disease datasets provided by the UCI Machine Learning Repository.
The size for the file featured within this Kaggle dataset is shown below — along with a list of attributes, and their description summaries:
- thyroidDF.csv - 9172 observations x 31 attributes
The diagnosis consists of a string of letters indicating diagnosed conditions.
A diagnosis "-" indicates no condition requiring comment. A diagnosis of the
form "X|Y" is interpreted as "consistent with X, but more likely Y". The
conditions are divided into groups where each group corresponds to a class of
comments.
Letter Diagnosis
------ ---------
hyperthyroid conditions:
A hyperthyroid
B T3 toxic
C toxic goitre
D secondary toxic
hypothyroid conditions:
E hypothyroid
F primary hypothyroid
G compensated hypothyroid
H secondary hypothyroid
binding protein:
I increased binding protein
J decreased binding protein
general health:
K concurrent non-thyroidal illness
replacement therapy:
L consistent with replacement therapy
M underreplaced
N overreplaced
antithyroid treatment:
O antithyroid drugs
P I131 treatment
Q surgery
miscellaneous:
R discordant assay results
S elevated TBG
T elevated thyroid hormones
Thyroid Data - https://archive.ics.uci.edu/ml/datasets/thyroid+disease
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This data set contains 13 clinicopathologic features aiming to predict recurrence of well differentiated thyroid cancer. The data set was collected in duration of 15 years and each patient was followed for at least 10 years.
Source The data was procured from thyroid disease datasets provided by the UCI Machine Learning Repository.
Content The size for the file featured within this Kaggle dataset is shown below — along with a list of attributes, and their description summaries:
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Thyroid diseases are common, and use of levothyroxine is increasing worldwide. We investigated the influence of gender, race and socioeconomic status on the diagnosis and treatment of thyroid disorders using data from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), a multicenter cohort study of civil servants (35-74 years of age) from six Brazilian cities. Diagnosis of thyroid dysfunction was by thyrotropin (TSH), and free thyroxine (FT4) if TSH was altered, and the use of specific medications. Multivariate logistic regression models were constructed using overt hyperthyroidism/hypothyroidism and levothyroxine use as dependent variables and sociodemographic characteristics as independent variables. The frequencies of overt hyper- and hypothyroidism were 0.7 and 7.4%, respectively. Using whites as the reference ethnicity, brown, and black race were protective for overt hypothyroidism (OR=0.76, 95%CI=0.64-0.89, and OR=0.53, 95%CI=0.43-0.67, respectively, and black race was associated with overt hyperthyroidism (OR=1.82, 95%CI=1.06-3.11). Frequency of hypothyroidism treatment was higher in women, browns, highly educated participants and those with high net family incomes. After multivariate adjustment, levothyroxine use was associated with female gender (OR=6.06, 95%CI=3.19-11.49) and high net family income (OR=3.23, 95%CI=1.02-10.23). Frequency of hyperthyroidism treatment was higher in older than in younger individuals. Sociodemographic factors strongly influenced the diagnosis and treatment of thyroid disorders, including the use of levothyroxine.
Facebook
Twitterthis dataset 0 raw and 0 features
Facebook
TwitterAttribution-ShareAlike 4.0 (CC BY-SA 4.0)https://creativecommons.org/licenses/by-sa/4.0/
License information was derived automatically
This dataset is a cleaned, transformed, and research-informed version of the original Thyroid Disease records compiled by the Garavan Institute and J. Ross Quinlan (1984–1987). It contains 9,000+ patient records with lab values, clinical history, and diagnosis outcomes. All missing values (?) were removed, and redundant or conflicting entries were dropped.
The dataset is valuable for Healthcare and Medical Research focused on thyroid-related Health Conditions. It supports Multiclass Classification problems in Artificial Intelligence and Data Analytics, particularly within Computer Science and Healthcare domains.
Missing values have been removed and categorical flags (t/f) converted to boolean (True/False). Meaningful multiclass target labels were created based on clinical diagnosis codes, including handling ambiguous cases. Data types were adjusted for compatibility with machine learning workflows using tools like pandas, NumPy, and scikit-learn.
This dataset is suitable for users of all skill levels—Beginner, Intermediate, and Advanced—interested in exploring Classification, Feature Extraction, Data Cleaning, and Exploratory Data Analysis in healthcare datasets. Visualizations can be developed using Matplotlib and Seaborn to better understand thyroid disease patterns.
Boolean fields (t/f) were converted to True/False, and a meaningful target variable was created based on clinically grounded groupings described in the research article “Thyroid Disease Prediction Using Selective Features and Machine Learning Techniques” (PMCID: PMC9405591).
The original diagnosis strings (e.g., A|B) were resolved to reflect the most likely class, and diagnoses were mapped into simplified, interpretable categories suitable for classification tasks (e.g., hypothyroid, hyperthyroid, normal, etc.).
This version is optimized for machine learning applications such as:
Classification of thyroid status (e.g., binary or multi-class)
Feature selection and model evaluation
Clinical decision support research
Ideal for healthcare ML projects, educational purposes, and benchmarking thyroid disorder prediction models.
Facebook
TwitterThe estimated prevalence of thyroid disorder increased in Italy from 2016 to 2022. In 2016, around ** percent of the Italian clients of general practitioners suffered from thyroid disorders. In 2021 and 2022, the prevalence of this disorder in Italy was **** percent, the highest figure registered in the period under consideration. This statistic displays the prevalence of thyroid disorder in Italy from 2016 to 2022.
Facebook
Twitterdataset thyroid that contains 2777 raws and 30 feature
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Supplementary Material 1 Supporting information files_data set1
Facebook
Twitterhttps://www.mordorintelligence.com/terms-and-conditionshttps://www.mordorintelligence.com/terms-and-conditions
Complete dataset included in the full report. Detailed tables, regional splits, forecasts, and methodologies are available with purchase.
Facebook
TwitterExplore 53 genes associated with Thyroid disease on GeDiPNet, including gene-disease associations, pathways, source IDs, and references for research.
Facebook
Twitter45 raw data
Facebook
TwitterIntroductionOvulatory dysfunction is usually caused by an endocrine disorder, of which polycystic ovary syndrome (PCOS) is the most common cause. PCOS is usually associated with estrogen levels within the normal range and can be characterized by oligo-/anovulation resulting in decreased progesterone levels. It is suggested that decreased progesterone levels may lead to more autoimmune diseases in women with PCOS. In addition, it is often claimed that there is an association between hyperprolactinemia and PCOS. In this large well-phenotyped cohort of women with PCOS, we have studied the prevalence of thyroid dysfunction and hyperprolactinemia compared to controls, and compared this between the four PCOS phenotypes.MethodsThis retrospective cross-sectional study contains data of 1429 women with PCOS and 299 women without PCOS. Main outcome measures included thyroid stimulating hormone (TSH), Free Thyroxine (FT4), and anti-thyroid peroxidase antibodies (TPOab) levels in serum, the prevalence of thyroid diseases and hyperprolactinemia.ResultsThe prevalence of thyroid disease in PCOS women was similar to that of controls (1.9% versus 2.7%; P = 0.39 for hypothyroidism and 0.5% versus 0%; P = 0.99 for hyperthyroidism). TSH levels were also similar (1.55 mIU/L versus 1.48 mIU/L; P = 0.54). FT4 levels were slightly elevated in the PCOS group, although within the normal range (18.1 pmol/L versus 17.7 pmol/L; P ConclusionWomen with PCOS do not suffer from thyroid dysfunction more often than controls. Also, the prevalence of positive TPOab, being a marker for future risk of thyroid pathology, was similar in both groups. Furthermore, the prevalence of hyperprolactinemia was similar in women with PCOS compared to controls.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
BackgroundAs a product of adipose tissue, resistin exceeds other adipokines in its role in regulating appetite, energy expenditure, insulin sensitivity, inflammation, and immunity, similar to thyroid hormones. This study aimed to evaluate the association between resistin levels and thyroid dysfunction and to explore variations in circulating resistin levels before and after treatment for thyroid dysfunction.MethodsThis study was conducted according to the Preferred Reporting Items for Systematic Review and Meta-Analysis statement. A comprehensive search of PubMed, Embase, and Cochrane databases was conducted until June 15, 2022, with no start date restriction, according to the preregistered protocol (PROSPERO-CRD42022336617). RevMan version 5.4 and R software package version 4.2.0 were used for statistical analyses.ResultsFourteen studies with 1716 participants were included in this study. The findings of the meta-analysis confirmed that the resistin levels of patients with thyroid dysfunction were significantly higher than those of the euthyroid function control group (mean difference [MD] = 2.11, 95% confidence interval [CI] = 1.11–3.11, P < 0.00001). Furthermore, the resistin levels of patients with hyperthyroidism (MD = 3.23, 95% CI = 0.68–5.79, P = 0.01) and subclinical hypoidism (MD = 1.37, 95% CI = 0.31–2.42, P = 0.01) were significantly higher than those of euthyroid controls. The resistin levels of patients with thyroid dysfunction after treatment were significantly lower than those before treatment (MD = 1.00, 95% CI = 0.34–1.65, P = 0.003), especially in patients with hyperthyroidism (MD = 2.16, 95% CI = 1.00–3.32, P = 0.0003). Correlation analysis confirmed a positive correlation between resistin levels and free triiodothyronine (FT3) levels in patients with thyroid dysfunction (r = 0.27578, P = 0.001).ConclusionsOur meta-analysis demonstrates that resistin levels are significantly higher in patients with thyroid dysfunction, and the resistin levels after treatment in patients with thyroid dysfunction are significantly lower than those before treatment. Correlation analysis shows a positive correlation between resistin levels and FT3 levels in patients with thyroid dysfunction.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022336617.
Facebook
TwitterBackground: In adults, a significant impact of thyroid dysfunction and autoimmunity on health-related quality of life (HRQoL) and mental health is described. However, studies in children and adolescents are sparse, underpowered, and findings are ambiguous.Methods: Data from 759 German children and adolescents affected by thyroid disease [subclinical hypothyroidism: 331; subclinical hyperthyroidism: 276; overt hypothyroidism: 20; overt hyperthyroidism: 28; Hashimoto's thyroiditis (HT): 68; thyroid-peroxidase antibody (TPO)-AB positivity without apparent thyroid dysfunction: 61] and 7,293 healthy controls from a nationwide cross-sectional study (“The German Health Interview and Examination Survey for Children and Adolescents”) were available. Self-assessed HRQoL (KINDL-R) and mental health (SDQ) were compared for each subgroup with healthy controls by analysis of covariance considering questionnaire-specific confounding factors. Thyroid parameters (TSH, fT4, fT3, TPO-AB levels, thyroid volume as well as urinary iodine excretion) were correlated with KINDL-R and SDQ scores employing multiple regression, likewise accounting for confounding factors.Results: The subsample of participants affected by overt hypothyroidism evidenced impaired mental health in comparison to healthy controls, but SDQ scores were within the normal range of normative data. Moreover, in no other subgroup, HRQoL or mental health were affected by thyroid disorders. Also, there was neither a significant relationship between any single biochemical parameter of thyroid function and HRQoL or mental health, nor did the combined thyroid parameters account for a significant proportion of variance in either outcome measure. Importantly, the present study was sufficiently powered to identify even small effects in children and adolescents affected by HT, subclinical hypothyroidism, and hyperthyroidism.Conclusions: In contrast to findings in adults, and especially in HT, there was no significant impairment of HRQoL or mental health in children and adolescents from the general pediatric population affected by thyroid disease. Moreover, mechanisms proposed to explain impaired mental health in thyroid dysfunction in adults do not pertain to children and adolescents in the present study.
Facebook
TwitterApache License, v2.0https://www.apache.org/licenses/LICENSE-2.0
License information was derived automatically
Thyroid disease datasets typically contain information about patients, including various attributes such as age, sex, thyroid hormone levels (TSH, T3, T4), medical history, and possibly symptoms or other relevant factors. These datasets are valuable for research purposes, particularly in the fields of endocrinology, machine learning, and healthcare analytics.
Several datasets are available for research purposes, often sourced from hospitals, research institutions, or public health agencies. Here are some common sources where you might find thyroid disease datasets:
UCI Machine Learning Repository: This repository hosts various datasets for machine learning research, and it includes some datasets related to thyroid disease.
Kaggle: Kaggle is a platform for data science and machine learning competitions, and it also hosts datasets for various purposes. You might find thyroid disease datasets shared by users or organizations.
Healthcare Databases: Some hospitals or healthcare institutions maintain databases with anonymized patient data, including information about thyroid diseases. Access to these datasets may require appropriate permissions and approvals due to privacy concerns.
Research Publications: Researchers often publish datasets along with their research papers. Searching through academic journals and repositories may lead you to relevant datasets related to thyroid diseases.
When working with any healthcare-related dataset, it's crucial to handle the data with care, ensuring patient privacy and adhering to ethical guidelines and regulations such as HIPAA (in the United States) or GDPR (in the European Union), depending on the jurisdiction.
If you need assistance finding a specific dataset or have other questions about thyroid disease datasets, feel free to ask!
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Thyroid disease presents a significant health risk, lowering the quality of life and increasing treatment costs. The diagnosis of thyroid disease can be challenging, especially for inexperienced practitioners. Machine learning has been established as one of the methods for disease diagnosis based on previous studies. This research introduces a novel and more effective technique for predicting thyroid disease by utilizing machine learning methodologies, surpassing the performance of previous studies in this field. This study utilizes the UCI thyroid disease dataset, which consists of 9172 samples and 30 features, and exhibits a highly imbalanced target class distribution. However, machine learning algorithms trained on imbalanced thyroid disease data face challenges in reliably detecting minority data and disease. To address this issue, re-sampling is employed, which modifies the ratio between target classes to balance the data. In this study, the down-sampling approach is utilized to achieve a balanced distribution of target classes. A novel RF-based self-stacking classifier is presented in this research for efficient thyroid disease detection. The proposed approach demonstrates the ability to diagnose primary hypothyroidism, increased binding protein, compensated hypothyroidism, and concurrent non-thyroidal illness with an accuracy of 99.5%. The recommended model exhibits state-of-the-art performance, achieving 100% macro precision, 100% macro recall, and 100% macro F1-score. A thorough comparative assessment is conducted to demonstrate the viability of the proposed approach, including several machine learning classifiers, deep neural networks, and ensemble voting classifiers. The results of K-fold cross-validation provide further support for the efficacy of the proposed self-stacking classifier.
Facebook
Twitterhttps://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
According to Cognitive Market Research, the global Thyroid Functioning Tests market size will be USD 4968.5 million in 2025. It will expand at a compound annual growth rate (CAGR) of 7.00% from 2025 to 2033.
North America held the major market share for more than 40% of the global revenue with a market size of USD 1838.35 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2033.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1440.8 million.
APAC held a market share of around 23% of the global revenue with a market size of USD 1192.4 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2033.
South America has a market share of more than 5% of the global revenue with a market size of USD 188.80 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2033.
Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 198.74 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2033.
Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 109.31 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2033.
Power Filters category is the fastest growing segment of the Thyroid Functioning Tests industry
Market Dynamics of Thyroid Functioning Tests Market
Key Drivers for Thyroid Functioning Tests Market
Rising Prevalence of Thyroid Disorders to Boost Market Growth
Hypothyroidism and hyperthyroidism are becoming increasingly prevalent worldwide due to factors such as genetics, lifestyle changes, and environmental influences. Over 12 percent of the U.S. population will develop a thyroid condition at some point in their lives, and an estimated 20 million Americans currently have some form of thyroid disease. However, up to 60 percent of those with thyroid conditions are unaware of their diagnosis. Women are more likely to experience thyroid issues, with the risk being five to eight times higher than that of men. In fact, one in eight women will develop a thyroid disorder during their lifetime. These conditions can have a significant impact on metabolism and overall health, contributing to a growing demand for thyroid function tests. Additionally, autoimmune diseases, such as Hashimoto's thyroiditis (a common cause of hypothyroidism) and Graves' disease (which causes hyperthyroidism), are becoming more prevalent, further increasing the need for regular screening. As the global population ages, the likelihood of developing thyroid disorders, particularly hypothyroidism, also rises. This aging demographic requires more routine testing to monitor and manage thyroid health.
https://www.thyroid.org/media-main/press-room//./
Rise in Lifestyle-related Risk Factors to Boost Market Growth
Increasing stress, poor diet, lack of physical activity, and environmental pollution are major risk factors for thyroid disorders. Approximately 284 million people worldwide suffer from anxiety disorders, and nearly 90% of U.S. adults report losing sleep due to concerns about health and the economy. Additionally, about 75% of Americans experience physical or mental symptoms of stress, with more than three-quarters of adults reporting issues such as headaches, fatigue, and depression. These lifestyle changes are contributing to a higher incidence of thyroid-related problems, which is driving the growing demand for thyroid function tests. Furthermore, exposure to chemicals and toxins in the environment, including those found in certain pesticides, has been linked to thyroid dysfunction, further increasing the need for regular monitoring.
https://www.singlecare.com/blog/news/stress-statistics/./
Restraint Factor for the Thyroid Functioning Tests Market
High Cost of Advanced Diagnostic Tests and Challenges in Test Accuracy and Standardization, Will Limit Market Growth
The cost of diagnostic equipment for thyroid function tests, such as automated analyzers and high-quality reagents, can be prohibitively expensive, especially for small clinics and healthcare facilities in emerging markets. Additionally, testing at high-end laboratories or through advanced diagnostic platforms often comes with higher costs, which may discourage patients from undergoing regular testing. Th...
Facebook
Twitterthis dataset content 10 raw and 30 featurs
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This article analyzes the importance of modern diagnostic methods in the early detection of thyroid diseases, their advantages and limitations, as well as the possibilities of their application based on a comprehensive approach. Thyroid pathologies are widespread among endocrine system diseases, characterized by a long-term latent course and detection in late stages. According to the World Health Organization, approximately 5-10% of the world's population suffers from thyroid dysfunction of varying degrees. The article examines the effectiveness of ultrasound examination (US), laboratory hormonal tests (TSH, T3, T4), and non-invasive diagnostic methods. In particular, the accuracy of detecting nodular changes using ultrasound is 85-95%. It was also noted that the ability to differentially diagnose benign and malignant changes using fine needle aspiration biopsy (FNAB) has an accuracy of 90–97%. In modern approaches, the integrated use of laboratory and instrumental methods in diagnosing thyroid diseases significantly increases diagnostic accuracy
Facebook
TwitterExplore 144 genes associated with Autoimmune thyroid disease on GeDiPNet, including gene-disease associations, pathways, source IDs, and references for research.
Facebook
Twitterhttps://creativecommons.org/publicdomain/zero/1.0/https://creativecommons.org/publicdomain/zero/1.0/
The datasets featured below were created by reconciling thyroid disease datasets provided by the UCI Machine Learning Repository.
The size for the file featured within this Kaggle dataset is shown below — along with a list of attributes, and their description summaries:
- thyroidDF.csv - 9172 observations x 31 attributes
The diagnosis consists of a string of letters indicating diagnosed conditions.
A diagnosis "-" indicates no condition requiring comment. A diagnosis of the
form "X|Y" is interpreted as "consistent with X, but more likely Y". The
conditions are divided into groups where each group corresponds to a class of
comments.
Letter Diagnosis
------ ---------
hyperthyroid conditions:
A hyperthyroid
B T3 toxic
C toxic goitre
D secondary toxic
hypothyroid conditions:
E hypothyroid
F primary hypothyroid
G compensated hypothyroid
H secondary hypothyroid
binding protein:
I increased binding protein
J decreased binding protein
general health:
K concurrent non-thyroidal illness
replacement therapy:
L consistent with replacement therapy
M underreplaced
N overreplaced
antithyroid treatment:
O antithyroid drugs
P I131 treatment
Q surgery
miscellaneous:
R discordant assay results
S elevated TBG
T elevated thyroid hormones
Thyroid Data - https://archive.ics.uci.edu/ml/datasets/thyroid+disease